VANCOUVER, BC / ACCESS Newswire / February 4, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it has filed a preliminary base shelf prospectus dated February 3, 2026 (the "Base Shelf Prospectus") with the securities regulatory authorities in each of the provinces of Alberta, British Columbia, Manitoba and Ontario. The Base Shelf Prospectus has been filed, but is not yet final, and the securities described therein may not be s ...

Core Insights - Nike co-founder Phil Knight is making a historic donation of $2 billion to the Oregon Health and Science University's Cancer Institute, marking the largest single donation to a U.S. university, college, or health institution [1] - The donation aims to transform the scientific approach to cancer treatment, research, and patient care outcomes, in collaboration with cancer research pioneer Dr. Brian Druker [1] Group 1 - The Knights previously committed to matching a $500 million fundraising challenge for cancer research initiated by Druker and OHSU [2] - Phil and Penny Knight expressed their excitement about the transformational potential of this investment in cancer research, diagnosis, treatment, and care [2]

Core Points - AbbVie has launched a multi-year partnership with the Chicago Cubs to support cancer advocacy through the "Striking Out Cancer" campaign, which begins with the Cubs' game against the Cincinnati Reds [1][3] - For every strikeout by a Cubs pitcher at home during the 2025 regular season, AbbVie will donate $233, reflecting the statistic of approximately 233 Americans diagnosed with cancer every hour [1][2] - The funds raised will be donated to Cubs Charities, benefiting non-profit organizations like Conquer Cancer®, which focuses on advancing cancer research and patient care [1][3][7] Company Overview - AbbVie is a global biopharmaceutical company dedicated to discovering and delivering transformative medicines across various therapeutic areas, including oncology [2][4] - The company aims to address serious health issues and improve patient outcomes through innovative therapies for cancers such as leukemias, lymphomas, and lung cancer [2][4] Partner Overview - The Chicago Cubs, a historic Major League Baseball franchise, have a commitment to community engagement and charitable initiatives, including the "Striking Out Cancer" campaign [5][6] - Cubs Charities has invested over $51 million in community programs since 2009, focusing on youth development and safe play environments [6] Beneficiary Overview - Conquer Cancer®, the ASCO Foundation, has awarded over $203 million in grants to improve cancer care and research since its inception in 1984 [7]